HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Girish V Shah Selected Research

Calcitonin (Calcitonin, Eel)

1/2016A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.
9/2013Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.
3/2009Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.
1/2009Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer.
12/2008Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.
1/2007Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
7/2006The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
11/2005Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
5/2005Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Girish V Shah Research Topics

Disease

11Prostatic Neoplasms (Prostate Cancer)
01/2016 - 07/2004
10Neoplasms (Cancer)
03/2016 - 07/2004
3Neoplasm Metastasis (Metastasis)
03/2009 - 07/2004
1Adenocarcinoma
03/2016
1Breast Neoplasms (Breast Cancer)
01/2009

Drug/Important Bio-Agent (IBA)

9Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2016 - 05/2005
4Calcitonin Receptors (Calcitonin Receptor)IBA
09/2013 - 01/2007
4Messenger RNA (mRNA)IBA
01/2009 - 05/2005
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2009 - 01/2007
2beta CateninIBA
03/2009 - 01/2009
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2009 - 11/2005
2Carbon MonoxideIBA
12/2008 - 11/2005
1Prostate-Specific Antigen (Semenogelase)IBA
03/2016
1NeuropeptidesIBA
01/2016
1Phosphotransferases (Kinase)IBA
01/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2009
1VimentinIBA
01/2009
1Matrix MetalloproteinasesIBA
01/2009
1ceramide glucosyltransferaseIBA
01/2009
1Antineoplastic Agents (Antineoplastics)IBA
01/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2009
1Catalytic RNA (Ribozymes)IBA
12/2008
1probasinIBA
12/2008
1matrigelIBA
03/2008
1Dihydrotachysterol (AT 10)IBA
03/2008
1Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2007
1Fibronectins (Fibronectin)IBA
07/2006
1Adenylate Cyclase (Adenylyl Cyclase)IBA
11/2005
1CalciumIBA
11/2005
1Cyclic AMP (AMP, Cyclic)IBA
05/2005
1Glycoproteins (Glycoprotein)IBA
07/2004
1Protein Isoforms (Isoforms)IBA
07/2004

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
01/2009
1Drug Therapy (Chemotherapy)
01/2009
1Prostatectomy (Retropubic Prostatectomy)
07/2004